The Clinical Gap
Panic attacks are acute episodes of intense physiological arousal, with elevated heart rate, HRV suppression, and hyperventilation, that affect approximately 11% of the population annually. Despite being physiologically measurable, they are almost never detected in real time. Current interventions are reactive: the patient recognizes the episode and manually initiates a coping protocol, often after the peak has passed.
The opportunity is to detect the onset automatically, before the patient is overwhelmed, and deliver an immediate guided intervention, reducing episode severity and duration.
Device Architecture
The system was architected as an FDA Class II medical device under the de novo pathway, given that no substantially equivalent predicate exists for an autonomous panic attack detection and intervention wearable.
The device runs on Apple Watch, using two onboard sensors:
- Optical PPG for real-time heart rate and HRV measurement
- Accelerometer for motion detection (to distinguish panic-induced stillness from sleep or rest)
The detection algorithm uses a threshold-based logic:
- HR increase greater than 20 bpm from baseline
- Absolute HR above 100 bpm
- HRV below 20 ms
- Motion below 0.2 g (ruling out exercise as the cause)
When all four conditions are met simultaneously, the system classifies the state as a probable panic episode and triggers the intervention automatically.
The Intervention
Once a panic state is detected, the device launches a guided breathing protocol without requiring user input. The screen shifts to a visual breathing coach ("Breathe in / Breathe out" with a pacing animation) and delivers synchronized haptic feedback.
The protocol runs for 5 cycles by default, with the option to extend. The design rationale: haptic and visual feedback is less socially visible than audio, making the intervention usable in professional or public settings without stigma. Discreteness and minimal social footprint were explicit design requirements.
Regulatory and Quality Framework
The device specification followed ISO 13485 Quality Management System requirements for medical device design controls: defined intended use, user profile, use environment, and risk analysis following ISO 14971.
The target performance specification was greater than 80% Positive Predictive Value, meaning fewer than 1 in 5 alerts would be a false positive. At this PPV level, the intervention remains clinically credible and user trust in the system is maintained.
The prototype was validated as a functional concept with a working watchOS simulator. Clinical validation on real physiological data during induced stress conditions was defined as the required next step before any regulatory submission.